High-Normal free triiodothyronine Levels Linked to Improved HDL and Lower Cholesterol, Study

While the profound impact of thyroid dysfunction on lipid metabolism—where thyroid hormones regulate the synthesis, mobilization, and degradation of lipids—is well-established, the specific relationship between these hormones and lipid parameters in individuals with normal thyroid function has remained clinically ambiguous and controversial. To address this uncertainty and identify potential metabolic markers, RS Sudharshini and colleagues from the Department of Biochemistry and General Medicine at Trichy SRM Medical College Hospital and Research Centre conducted an investigation to determine how thyroid-stimulating hormone (TSH) and free thyroxine (fT4) influence the lipid health of euthyroid adults.

Therefore, the ten-month cross-sectional observational study, conducted between March and December 2023 at a tertiary care hospital in Southern India, analyzed a cohort of 100 healthy adults to map the interplay between thyroid hormones and derived markers like the TSH index (TSHI) and the fT3/fT4 ratio. Using chemiluminescence immunoassay and automated enzymatic colorimetric methods, the researchers compared hormonal data against fasting lipid profiles while strictly excluding participants with histories of thyroid illness or those using medications like steroids or anti-lipid therapies to ensure the integrity of the primary and secondary endpoints.

Key Clinical Findings of the Study Include:

• Positive HDL Correlation: The study identified that fT3 possesses a statistically significant positive association with HDL (r = 0.4, p = 0.01), suggesting that higher normal hormone levels may support cardiovascular health.

• Total Cholesterol Inverse Relationship: It was observed through the research data that increasing fT3 levels are associated with a significant negative correlation with TC concentrations (r = -0.3, p = 0.04), indicating a natural regulatory effect on blood fats.

• Gender-Specific Metabolic Links: The investigators noted that the favorable associations between thyroid parameters—specifically fT3 (r = 0.6) and fT4 (r = 0.4)—and HDL reached statistical significance exclusively in the male cohort.

• Influence of High-Normal TSH: In a focused subgroup analysis of subjects with TSH levels ≥ 3 µIU/mL, the investigation found that fT3 exhibited a robust negative correlation with low-density lipoprotein (LDL) cholesterol (r = -0.7, p = 0.001).

• Peripheral Sensitivity Impact: The analysis highlighted that a higher fT3/fT4 ratio was significantly linked to improved HDL levels (r = 0.5, p < 0.001) and associated with triglyceride (TG) and very-low-density lipoprotein (VLDL) in specific subgroups.

The results suggest that among euthyroid individuals, higher fT3 levels are consistently associated with a more favorable lipid profile, particularly in subjects where TSH is at the higher end of the normal range (≥ 3 µIU/mL), evidenced by significant reductions in LDL (r = -0.7) and total cholesterol (r = -0.5).

These findings imply that clinicians should consider the potential future utility of hepatoselective thyroid hormone receptor beta-selective agonists or hormone analogs in the management of dyslipidemia due to their intimate association with lipid regulation.

Although the study provides valuable insights, it was limited by a small sample size and the absence of thyroid autoantibody measurements, indicating that while the findings are attractive for clinical practice, they require validation through larger-scale future research trials.

Reference

Sudharshini RS, Velayutharaj A, Mohan M, et al. Thyroid Hormone Levels, even within the Euthyroid Range, are Associated with Lipid Levels. J Assoc Physicians India 2026;74(4):14–17.